Results
eNauka >
Rezultati >
What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia
| Naziv: | What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia | Autori: | Adžić-Vukičević, Tatjana N. |
Godina: | 2023 | Publikacija: | Frontiers in medicine | ISSN: | 2296-858X Frontiers in Medicine Pretraži identifikator |
Izdavač: | Lausanne, Switzerland : Frontiers Media S.A. | Tip rezultata: | Naučni članak | Kolacija: | vol. 10 str. 1253135 | DOI: | 10.3389/fmed.2023.1253135 | WoS-ID: | 001170469700001 | Scopus-ID: | 2-s2.0-85178030659 | PMID: | 38034537 | PMCID: | PMC10683091 | URI: | https://enauka.gov.rs/handle/123456789/939037 | URL: | https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1253135/full | Projekat: | Ministry of Health10.13039/501100004726 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.